文献速递肿瘤 PET/CT放射性药物与辐射防护

结核病影像学进展

Updates on tuberculosis imaging.
PubMed 文献 · Semin Nucl Med · 2026-04-23

本文综述了近十年来结核病分子影像的主要进展,重点为FDG PET/CT在结核病中的应用。新数据揭示了肉芽肿的时空演变、亚临床结核的代谢活跃性及其对进展的预测价值,且FDG PET/CT在治疗监测中优于传统微生物标志物。新兴示踪剂和计算模型有望进一步拓展影像在结核病诊疗中的价值。

要点

  • FDG PET/CT可揭示肉芽肿微解剖播散与异质性,影响治疗结局。
  • 无症状者中代谢活跃的亚临床结核常见,且强预测未来进展。
  • 治疗监测中FDG PET/CT优于微生物标志物,可识别复发风险。

核心结论

  • 分子影像尤其是FDG PET/CT正成为阐明结核病生物学和推动诊疗策略进步的核心工具。

研究设计与样本

  • 本文为综述,聚焦于既往Seminars in Nuclear Medicine综述之后发表的结核病影像学研究。

主要发现

  • 非人灵长类和人类PET/CT数据揭示肉芽肿呈高度局限的微解剖种植、支气管播散途径及异质性病变生物学。
  • 无症状个体影像研究显示代谢活跃的亚临床结核常见,且强预测未来进展。
  • 治疗监测中FDG PET/CT与病灶层面灭菌相关,并识别复发风险,尤其治疗结束时持续代谢活动者。
  • 整合素靶向等新兴示踪剂可互补表征肉芽肿血管生成、免疫微环境和宿主-病原体动态。

临床怎么用

  • FDG PET/CT可用于结核病治疗监测,识别病灶灭菌情况和复发风险。
  • 对无症状个体,影像发现的代谢活跃亚临床结核提示未来进展风险,需关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tuberculosis (TB) remains a leading infectious cause of morbidity and mortality worldwide, and major diagnostic and therapeutic challenges persist despite advances in microbiologic and molecular testing. Over the past decade, molecular imaging, especially with FDG PET/CT, has transformed our understanding of TB pathogenesis, the spectrum of early and subclinical disease, mechanisms of dissemination, and treatment response. This review synthesizes key recent developments in TB imaging, focusing on studies published since prior Seminars in Nuclear Medicine reviews. New non-human primate and human PET/CT data provide unprecedented insight into the spatial and temporal evolution of granulomas, demonstrating highly localized microanatomic seeding, bronchogenic spread pathways, and heterogeneous lesion biology that strongly influence treatment outcomes. Imaging studies in asymptomatic individuals reveal that metabolically active subclinical TB is common and strongly predictive of future progression, redefining the spectrum of latent infection. In treatment monitoring, FDG PET/CT consistently outperforms conventional microbiologic biomarkers, correlating with lesion-level sterilization and identifying patients at risk for relapse, particularly when persistent metabolic activity remains at the end of therapy. The introduction of emerging tracers, such as integrin-targeted probes, offers complementary characterization of granuloma angiogenesis, immune microenvironments, and host-pathogen dynamics beyond glucose metabolism. Future priorities include the development of TB-specific radiotracers, the integration of PET with advanced computational modeling and AI-based quantification, and the translation of imaging biomarkers into individualized treatment strategies and drug-development pipelines. Collectively, these advances position molecular imaging as a central tool in elucidating TB biology and accelerating progress toward improved diagnostic, therapeutic, and prevention strategies.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Lawal IO, Ankrah AO, Abubakar S, et al. Updates on tuberculosis imaging. Semin Nucl Med. 2026. PMID: 42025532. doi:10.1053/j.semnuclmed.2026.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。